Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
-
England captain Stokes to retire from international cricket
-
Ogier wins Acropolis Rally to close in on Evans
-
South Africa maintain World Cup semi-final hopes with nervy win over Bangladesh
-
South Korea president apologises after World Cup group-stage exit
-
Japan's Ogura wins maiden MotoGP as Bezzecchi crashes in Assen
-
Bergs wins Eastbourne final to clinch first ATP title
-
Ravindra and Mitchell strengthen New Zealand's grip on England decider
-
Iran warns challenge to Hormuz routes will spike Middle East tensions
-
BIS warns 'pressure points' putting global economy at risk
-
From rubble to music: Gaza's Oud repairman
-
Ntamack aims to bring Toulouse Top 14 win 'energy' to Nations Championship campaign
-
Cycling industry bets on smart bikes to boost sales
-
'High-strung' camels race in Australian outback
-
In Idaho, the next generation of US nuclear reactors nears reality
-
Algeria and Austria reach World Cup knockouts after 3-3 thriller
-
Africa the winner of expanded World Cup amid mixed fortunes for minnows
-
DR Congo advance but Iran out as wild World Cup group stage wraps
-
Asia's vendors grapple with rising costs of ever-present plastics
-
Austria and Algeria reach World Cup knockouts after 3-3 thriller
-
Messi scores again as Argentina head into World Cup last 32 on a high
-
Where are they? Dogs disappear before South Korea meat ban
-
Wissa proud to deliver World Cup joy to war-torn DR Congo
-
China's bull wrestlers fight to keep tradition alive
-
South Korea's 'dismal' World Cup ends in group phase
-
England top group to set up DR Congo World Cup clash, Portugal held
-
Colombia and Portugal through to World Cup last 32 after thrilling draw
-
England moving on at World Cup but questions linger
-
Wissa sends DR Congo into World Cup last 32 clash with England
-
Venezuela quakes kill 1,400 as time running out to find survivors
-
A painful wait by a pile of rubble in quake-hit Venezuela
-
Australia World Cup goalkeeper Patrick Beach has beach named after him
-
Tuchel delighted to have Bellingham in 'sweet spot' for England at World Cup
-
Take brutally hot weather seriously, heatstroke survivor warns
-
Bellingham says 'job done' but England must improve at World Cup
-
Australia boosts shark-spotting drone coverage at Sydney beaches
-
Trump threatens to annihilate Iran after new exchange of attacks
-
Scotland boss Clarke resigns after World Cup exit confirmed
-
ELEKTROS Inc. Unveils Bold Expansion Strategy to Build a High-Speed EV Charging Network and Strengthen Its Long-Term Infrastructure Vision
-
ELEKTROS Inc. Advances Its EV Infrastructure Vision as Company Pursues High-Speed Charging Locations, Strategic Installation Capabilities and Long-Term Brand Expansion
-
ELEKTROS Inc. Accelerates Its EV Infrastructure Vision With Planned High-Speed Charging Network and Strategic Growth Initiative
-
Scotland boss Clarke resigns after World Cup exit confirmed: official
-
Kane, Bellingham on target as England win World Cup group
-
Kane, Bellingham on target as England clinch top spot
-
Croatia battle past Ghana to sew up World Cup Last 32 spot
-
Bellingham, Kane score as England beat Panama to reach World Cup last 32
-
US, Iran clash, putting fragile deal under growing strain
-
Canada's Davies 'available' for historic knockout clash
-
Ryu takes one-shot lead over Henderson at Women's PGA Championship
-
Hovland seizes one-shot PGA Travelers lead over Scheffler
-
Jangoo and Chase put West Indies in control against Sri Lanka
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
DORADO, PUERTO RICO / ACCESS Newswire / March 17, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the quarter ended January 31, 2025 were approximately $2.5 million, an increase of approximately $0.1 million when compared to the same period last year. Net income for the quarter ended January 31, 2025 was almost breakeven, representing an earnings increase of approximately $0.3 million when compared to the same period last year.
"As reflected in this quarter's results, we began experiencing net revenue growth in the markets we serve. With projects underway in Europe, Asia, and Latin America, we are poised for continued expansion as we drive growth by anticipating client needs and delivering unmatched solutions," stated Mr. Sanchez, Chief Executive Officer of the Company.
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
Forward-Looking Statements
This news release contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this earnings announcement. Although Pharma-Bio Serv's management believes these expectations, estimates, or projections to be reasonable as of the date of this earnings announcement, forward-looking statements are inherently subject to significant business risks, economic uncertainties, and competitive uncertainties, and other factors, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of Pharma-Bio Serv's Annual Report on Form 10-K for the year ended October 31, 2024, and in its other filings with the Securities and Exchange Commission, which filings are available at www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.
Company Contact:
Pedro J. Lasanta
Chief Financial Officer
787 278 2709
SOURCE: Pharma-Bio Serv Inc.
View the original press release on ACCESS Newswire
M.King--AT
